Genomic Vision SA
PAR:GV

Watchlist Manager
Genomic Vision SA Logo
Genomic Vision SA
PAR:GV
Watchlist
Price: 0.0018 EUR Market Closed
Market Cap: 694.6k EUR

Wall Street
Price Targets

GV Price Targets Summary
Genomic Vision SA

There are no price targets for GV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomic Vision SA Competitors:
Price Targets
REGN
Regeneron Pharmaceuticals Inc
14% Upside
PTGX
Protagonist Therapeutics Inc
5% Downside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
52% Upside
145020
Hugel Inc
98% Upside
VITR
Vitrolife AB
36% Upside
PEB
Pacific Edge Ltd
26% Downside
DTIL
Precision BioSciences Inc
511% Upside
CVAC
CureVac NV
6% Downside

Revenue
Forecast

Revenue Estimate
Genomic Vision SA

For the last 8 years the compound annual growth rate for Genomic Vision SA's revenue is -14%. The projected CAGR for the next 4 years is 19%.

-14%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genomic Vision SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Genomic Vision SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GV's stock price target?
Not Available

GV doesn't have any price targets made by Wall Street professionals.

What is Genomic Vision SA's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Genomic Vision SA's revenue is -14%. The projected CAGR for the next 4 years is 19%.

Back to Top